Niosh-Interactive Radioepidemiological Program (Niosh-Irep) Technical Documentation Final Report

By Department of Health and Human Services

Book Id: WPLBN0000141723
Format Type: PDF eBook
File Size: 2.1 MB
Reproduction Date: 2005

Title:	Niosh-Interactive Radioepidemiological Program (Niosh-Irep) Technical Documentation Final Report
Author:	Department of Health and Human Services
Volume:
Language:	English
Subject:	Health., Medical research, Medical reports
Collections:	Medical Library Collection
Historic Publication Date:
Publisher:	Centers for Disease Control and Prevention


Citation APA MLA Chicago Health And Human Services, D. O. (n.d.). Niosh-Interactive Radioepidemiological Program (Niosh-Irep) Technical Documentation Final Report. Retrieved from http://gutenberg.cc/

Excerpt
AND RECOMMENDED OCCUPATIONAL STANDARD ASBESTOS NOMENCLATURE/DEFONS Review General Definition ASBESTOS SAMPLING AND ANALYSIS BIOLOGIC EFFECTS OF EXPOSURE TO ASBESTOS IN ANIMALS In Vivo In Vitro BIOLOGIC EFFECTS OF EXPOSURE TO ASBESTOS IN HUMANS Axnosite Chrysotile Crocidolite Mixed Fiber '1s.pes Malignant Neoplasms other than Mesothelioma and Cancer of the Lung SMOKING AND ASBESTOS EXPOSURE TO ASBESTIFOM MINERALS OTHER THAN COMMERCIALLY MINED ASBESTOS NON-OCCUPATIONAL EXPOSURE TO COMMERCIAL SOURCES OF ASBESTOS DOSE-RESPONSE RELATIONSHIPS REFERENCES III PAGE 1 9 9 10 12 14 14 16 16 16 18 20 21 24 25...

Table of Contents
Table of Contents II . NIOSH-LREP and its implementation under EEOICPA . . . . . . . . . . . . . . . . . . . . . . . . . . . . .7 A . Dosimetry Issues ..................................................... 7 B . Cancers added to NIOSH-LREP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10 1. Bonecancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1.1 2 . Non-melanoma skin cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .1 4 3 . Malignant melanoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21 4 . Male breast cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2 4 5 . Connective tissue cancer. eye cancer. other endocrine cancer. and other and illdefined sites . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 26 C . Cancers excluded from NIOSH-IREP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27 1. Chronic lymphocytic leukemia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .2 7 D . Dose and dose-rate effectiveness factors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28 E . Radiation (type) effectiveness factors (REFS) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30 F . Definitions of smoking categories for lung cancer claims . . . . . . . . . . . . . . . . . . . . . 32 111 . Cancer model selection . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33 IV . Limitations of NIOSH-REP . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 35 V . References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60 Appendix I: NIOSH-REP program output . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 68 Appendix 11: Glossary of ICD-9 codes and their cancer descriptions . . . . . . . . . . . . . . . . . . . . . 71